Skip to main content
Menu
US

WGA-PEI TYPE A PS SPA Beads, 500 mg

WGA-coated SPA beads, for capturing cell membranes in proximity-based scintillation assays.

For research use only. Not for use in diagnostic procedures.

Feature Specification
Surface Treatment PEI
WGA

WGA-coated SPA beads, for capturing cell membranes in proximity-based scintillation assays.

Product Variant
Unit Size: 500 mg
Part #:
RPNQ0287
List Price
USD 7,803.00

Overview

WGA-coated SPA beads, for capturing cell membranes in proximity-based scintillation assays. 500 mg quantity.

The treatment of WGA SPA beads with positively charged polyethyleneimine (PEI) blocks potential non-specific binding sites on the SPA bead surface. There are two SPA bead types available with PEI treatment. The WGA-PEI type A SPA beads are treated with PEI prior to the coupling of WGA to the SPA bead. The WGA PEI type B SPA beads are treated with PEI after the WGA coupling stage. The WGA-PEI type A and type B SPA beads exhibit different characteristics with regard to the non-specific binding of radiolabelled ligand directly to the SPA bead. Therefore, both bead types should be evaluated when deciding which SPA bead to use and both are included in the Select-a-Bead Kit. The binding capacity of both bead types for cell membrane protein remains 10–30 μg membrane protein per milligram of SPA bead.

SPA Imaging beads are microspheres containing scintillant which emit light in the red region of the visible spectrum. As a result, these beads are ideally suited to use with a CCD imager, such as Revvity's Viewlux™ CCD Imager.

Two types of core SPA Imaging bead are available - yttrium oxide (YOx) and Polystyrene (PS). A number of biological coatings also exist for each core bead type to enable receptor binding, enzyme, molecular interaction and radioimmunoassays to be investigated.

Scintillation proximity assay (SPA) is a homogeneous and versatile technology for the rapid and sensitive assay of a wide range of biological processes, including applications using enzyme and receptor targets, radioimmunoassays, and molecular interactions. When 3H, 14C, 33P, and 125I radioisotopes decay, they release β-particles (or Auger electrons, in the case of 125I). The distance these particles travel through an aqueous solution is dependent on the energy of the particle. If a radioactive molecule is held in close enough proximity to a SPA Scintillation Bead or a SPA Imaging Bead, the decay particles stimulate the scintillant within the bead to emit light, which is then detected in a PMT-based scintillation counter or on a CCD-based imager, respectively. However, if the radioactive molecule does not associate with the SPA bead, the decay particles will not have sufficient energy to reach the bead and no light will be emitted. This discrimination of binding by proximity means that no physical separation of bound and free radiochemical is required.

Specifications

Application
Drug Discovery & Development
Automation Compatible
Yes
Bead Type or Material
Polystyrene (PS)
Brand
SPA Imaging Beads
Detection Modality
Radiometric
Format
Microplates
Tubes
Shipping Conditions
Shipped Ambient
Surface Treatment
PEI
WGA
Technology
Scintilation Proximity Assay
Unit Size
500 mg

Resources

Are you looking for resources, click on the resource type to explore further.

1-1 of 1 Resources
Guide Icon
Guide
Optimization of SPA receptor binding assays

Scintillation proximity assay has been successfully applied to receptor binding assays

SDS, COAs, Manuals and more

Are you looking for technical documents related to the product? We have categorized them in dedicated sections below. Explore now.

Safety data sheet
+ Show more
Technical data sheet
  • Lot number
    ANY
    Lot date
    September 15, 2023
+ Show more
Scroll Icon